CN106309992A - Traditional Chinese medicine composition for treating osteoproliferation - Google Patents

Traditional Chinese medicine composition for treating osteoproliferation Download PDF

Info

Publication number
CN106309992A
CN106309992A CN201610908729.8A CN201610908729A CN106309992A CN 106309992 A CN106309992 A CN 106309992A CN 201610908729 A CN201610908729 A CN 201610908729A CN 106309992 A CN106309992 A CN 106309992A
Authority
CN
China
Prior art keywords
chinese medicine
medicine composition
hyperosteogeny
traditional chinese
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610908729.8A
Other languages
Chinese (zh)
Inventor
蔡风宝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610908729.8A priority Critical patent/CN106309992A/en
Publication of CN106309992A publication Critical patent/CN106309992A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/58—Reptiles
    • A61K35/586—Turtles; Tortoises, e.g. terrapins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/648—Myriapods, e.g. centipedes or millipedes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A61K36/12—Filicopsida or Pteridopsida
    • A61K36/126—Drynaria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/51—Gentianaceae (Gentian family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/535—Perilla (beefsteak plant)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/69—Polygalaceae (Milkwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/716—Clematis (leather flower)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/85—Verbenaceae (Verbena family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for treating osteoproliferation. The composition is composed of the following 28 raw medicinal materials: medicated leaven, Chinese gall, cuttlebone, Chinese starjasmine stem, radix clematidis, folia perillae acutae, fructus viticis, cocklebur fruits, geranium wilfordii, dayflower, butterflybush flowers, swertia mileensis, rhizoma drynariae, cymbopogon distans, endive and the like. The traditional Chinese medicine composition disclosed by the invention can be prepared into clinically acceptable tablets, capsules, granules, pills, oral liquid, cream paste, sprays, ointments, liniments or tinctures by adding the conventional excipients according to the conventional process. The traditional Chinese medicine composition disclosed by the invention has the effects of promoting blood circulation to remove blood stasis, stimulating the circulation of the blood and causing the muscles and joints to relax, relieving pain and inflammation and the like, has obvious effects on treating symptoms such as cervical bone hyperplasia, lumbar vertebra bone hyperplasia, knee joint bone hyperplasia and the like, and does not have any toxic or side effect.

Description

A kind of Chinese medicine composition treating hyperosteogeny
Technical field
The present invention relates to a kind of Chinese medicine composition, particularly relate to a kind of Chinese medicine composition treating hyperosteogeny.
Background technology
Bone matrix hyperplasia is also known as hyperplastic osteoarthritis, osteoarthritis (OA), degenerative joint disease, senile joint Scorching, hypertrophiarthritis, is owing to constituting soft tissue degeneration, degeneration, the joint margins shapes such as the cartilage in joint, intervertebral disc, ligament Become bony spur, the changes such as synovial membrane is plump, and osteoclasia occurs, cause Secondary cases hyperosteogeny, cause joint deformity, when by abnormal During load, cause arthralgia, a kind of disease of the symptoms such as limitation of activity.Divide constitutional and Secondary cases two kinds.This disease mostly occurs In middle age or the old people of more than 45 years old, male was more than women, and heavy worker and athlete that conventional waist is movable are easy Suffer from this sick, be most commonly in the joints such as knee joint, hip, lumbar vertebra, cervical vertebra, elbow.
Summary of the invention
Present invention aim at providing a kind of Chinese medicine composition treating hyperosteogeny.
The present invention is achieved through the following technical solutions:
The crude drug of Chinese medicine composition of the present invention consists of:
The raw material composition of Chinese medicine composition of the present invention is preferably:
The raw material composition of Chinese medicine composition of the present invention is preferably:
The raw material composition of Chinese medicine composition of the present invention is preferably:
Chinese medicine composition of the present invention according to common process add customary adjuvant make the tablet of clinical acceptance, capsule, Granule, pill, oral liquid, emplastrum, spray, ointment, liniment or tincture.
Chinese medicine composition of the present invention has the effects such as blood circulation promoting and blood stasis dispelling, relaxing muscles and tendons and activating QI and blood in the collateral, anti-inflammatory analgetic, increases treatment cervical vertebra Raw, lumbar vertebra hyperosteogeny, the effect such as knee joint hyperosteogeny is notable, and has no side effect.
Experimental example is used for further illustrating the present invention below, but is not limited to the present invention.
One, clinical experiment
1, clinical observation
Emplastrum of the present invention (preparing according to embodiment 1 method) treatment hyperosteogeny 100 example, wherein male 50 example, women 50 examples.
2, medicament selection
Emplastrum of the present invention (is prepared according to embodiment 1 method), and 2 days/patch, 10 days be 1 course for the treatment of.
3, diagnostic criteria
1. this patient mostly is the middle-aged and elderly people of more than 40 years old, with the stiff pain of waist or the diseases such as numbness of lower limbs occur Shape, visible part patient's lumbar physiological-curvature of having a medical check-up is abnormal；Lumbar vertebra both sides muscle has tenderness.
2. the change (normotopia, position, side, left and right loxosis) of lumbar X line sheet, as patient can have lumbar curvature abnormal, lumbar vertebra side Curved, lumbar vertebra gap turn narrow, lumbar vertebra and facet joint hypertrophy, lumbar spondylolisthesis, intervertebral foramina stenosis etc. changes.
3. various symptoms produced by lumbar hyperosteogency should differentiate with multiple lumbar disc disease, such as prolapse of lumbar intervertebral disc Disease, vertebral body sends out the diseases such as the region between the heart and the diaphragm deformity, vertebral tumor, tuberculosis of spine.
4, criterion of therapeutical effect:
" in cure the desease Standardization of diagnosis and curative effect " implemented with reference to State Administration of Traditional Chinese Medicine 1994 drafts as follows:
Clinical recovery: tcm clinical practice symptom, sign disappear or substantially disappear；
Effective: tcm clinical practice symptom, sign substantially change；
Effective: tcm clinical practice symptom, sign all take a favorable turn；
Invalid: tcm clinical practice symptom, sign are all not improved；
5, therapeutic outcome
The Comparison of therapeutic of hyperosteogeny treated by table 1
Group Treatment number Recovery from illness Effective Effectively Invalid Total effective rate
Treatment group 100 86 8 6 0 100%
6, conclusion
Treatment group of the present invention uses emplastrum of the present invention to treat hyperosteogeny (preparing according to embodiment 1 method) two courses for the treatment of (10 days each courses for the treatment of), total effective rate is 100%.
Experimental example two, model case
Case 1: Zhang, female, 58 years old.Symptom: start at the beginning of patient 2012 to feel that left leg is swollen, tired at left hip joint Pain, whole left lower extremity is numb, does not check, carrying out closed treating with " prednisone ", symptom alleviates.In March, 2013 occurs again Above symptom.CT examination: lumbar vertebra L2-5 in hypertrophy in various degree, L3/4, L4/5 intervertebral disk hernia, oppress dural sac.June 13 Examine, little leg outer side pain numbness, during weight, cause the hip arthralgia, movable and overcast and rainy increase the weight of.Deep,thready and forceless pulse, red tongue, Aversion to cold and cold limbs.Diagnosis: lumbar vertebra hyperosteogeny；Treatment: blood circulation promoting and blood stasis dispelling, relaxing muscles and tendons and activating QI and blood in the collateral, anti-inflammatory analgetic；The application of the invention plaster Agent (preparing according to embodiment 1 method) is treated a course for the treatment of, and 2 days/patch, 10 days be 1 course for the treatment of.Arthralgia is clearly better, and knee joint closes Joint function is obviously improved, and patient can normally walk, and is continuing with a course for the treatment of, has the most recovered normal.
Case 2: Yao, man, 49 years old.Symptom: the strong pain of first quarter moon forward neck portion, numbness of the fingers, weight time light time dizzy, such as one time light Ordinary person, very dizzy during weight.Diagnosis: hyperosteogeny of cervical vertebra；Treatment: heat clearing away relaxing muscles and tendons, promoting blood circulation to remove obstruction in the collateral；By taking capsule of the present invention A course for the treatment of is treated in agent (preparing according to embodiment 2 method), and three times on the one, each two, 10 days be a course for the treatment of, and patient's dizziness is bright Aobvious alleviation.Continuing again to take a course for the treatment of, patient's cervical region pain by force disappears, and range of motion has recovered to normally.
Case 3: Lee so-and-so, female, 45 years old, first visit on June 14 in 2010.Main suit: the right gonalgia 5 years, increases the weight of 3 years. Medical history: starting before 5 years to occur that the right gonalgia, local are afraid of cool, the cloudy day increases the weight of whenever, and in October, 2009 takes the photograph sheet and shows: knee joint Hyperosteogeny, though seeking medical advice the most everywhere, forces on, and western medicines in treatment does not alleviates, and examines on June 14th, 2010, arteries and veins Heavy thin, light red tongue.Diagnosis: the rightest knee joint hyperosteogeny 2. rheumatic arthritis.Treatment: after detailed inspection, for patient Practical situation gives patient and takes Tablets (preparing according to embodiment 3 method), three times a day, each 2.Take one After the course for the treatment of (1 10 days course for the treatment of), pain is wholly absent.Continue to strengthen again and treat a course for the treatment of, recover normal the most completely.
Case 4, the Qin so-and-so, man, 55 years old, on June 8th, 2011 go to a doctor.Readme had slight lumbago gradually to cause right lower extremity before 20 years And vola constant pain, often because of tired or postemphasis of suffering from cold, over nearly one month, lumbago aggravation, lies awake all night, double lower limb swollen fiber crops of acid, Movable critical constraints, once took the photograph sheet prompting in certain hospital through CT: waist 4,5 vertebral body sclerotin is lip sample hypertrophy, right lateral recess stenosis and vertebra Manage narrow.Have a medical check-up: waist 4,5 vertebra interspinal interstice and right side tenderness (+), straight-leg raising test and strengthen test (+), right lower extremity and anus Door dermal sensation is gone down, and Achilles tendon reflex goes down.Diagnosis: lumbar vertebra hyperosteogeny and prolapse of lumbar intervertebral disc.Use ointment of the present invention After (preparing according to embodiment 4 method) course for the treatment of, flank pain alleviates, and is continuing with a course for the treatment of, and symptom, sign disappear completely Losing, spirit is straightforward.Follow up a case by regular visits to after 1 year, have no recurrence.
Following embodiment all can realize the effect of above-mentioned experimental example.
Detailed description of the invention
Embodiment 1 emplastrum
Said medicine is added customary adjuvant according to common process and makes emplastrum.2 days/patch.
Embodiment 2 capsule
Said medicine is added customary adjuvant according to common process and makes capsule.Three times a day, each 2.
Embodiment 3 tablet
Said medicine is added customary adjuvant according to common process and makes tablet.Three times a day, each 2.
Embodiment 4 ointment
Said medicine is added customary adjuvant according to common process and makes ointment.
Embodiment 5 granule
Said medicine is added customary adjuvant according to common process and makes granule.
Embodiment 6 spray
Said medicine is added customary adjuvant according to common process and makes spray.

Claims (7)

1. the Chinese medicine composition treating hyperosteogeny, it is characterised in that the crude drug of said composition consists of:
2. Chinese medicine composition as claimed in claim 1, it is characterised in that the crude drug of said composition consists of:
3. Chinese medicine composition as claimed in claim 1, it is characterised in that the crude drug of said composition consists of:
4. Chinese medicine composition as claimed in claim 1, it is characterised in that the crude drug of said composition consists of:
5. the Chinese medicine composition as described in one of claim 1-4, it is characterised in that said composition often adds according to common process Rule adjuvant makes the tablet of clinical acceptance, capsule, granule, pill, oral liquid, emplastrum, spray, ointment, liniment Or tincture.
6. the application in the medicine of preparation treatment hyperosteogeny of the Chinese medicine composition as described in one of claim 1-4.
7. the Chinese medicine composition as claimed in claim 6 application in the medicine of preparation treatment hyperosteogeny, it is characterised in that Described hyperosteogeny refers to hyperosteogeny of cervical vertebra, lumbar vertebra hyperosteogeny or knee joint hyperosteogeny.
CN201610908729.8A 2016-10-14 2016-10-14 Traditional Chinese medicine composition for treating osteoproliferation Pending CN106309992A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610908729.8A CN106309992A (en) 2016-10-14 2016-10-14 Traditional Chinese medicine composition for treating osteoproliferation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610908729.8A CN106309992A (en) 2016-10-14 2016-10-14 Traditional Chinese medicine composition for treating osteoproliferation

Publications (1)

Publication Number Publication Date
CN106309992A true CN106309992A (en) 2017-01-11

Family

ID=57818537

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610908729.8A Pending CN106309992A (en) 2016-10-14 2016-10-14 Traditional Chinese medicine composition for treating osteoproliferation

Country Status (1)

Country Link
CN (1) CN106309992A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106924673A (en) * 2017-04-24 2017-07-07 蔡风宝 A kind of Chinese medicine composition for treating osteoproliferation and its medicament preparation method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104623476A (en) * 2015-01-15 2015-05-20 李兆瑞 Traditional Chinese medicine composition for treating osteoproliferation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104623476A (en) * 2015-01-15 2015-05-20 李兆瑞 Traditional Chinese medicine composition for treating osteoproliferation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106924673A (en) * 2017-04-24 2017-07-07 蔡风宝 A kind of Chinese medicine composition for treating osteoproliferation and its medicament preparation method

Similar Documents

Publication Publication Date Title
CN102908442B (en) Composition for treating traumatic injuries and medicinal liquor thereof
CN102389532B (en) Pharmaceutical composition for treating pains in neck, shoulder, low-back and leg
CN103720851B (en) A kind of Chinese medicine decoction for the treatment of hyperosteogeny
CN104940704A (en) Traditional Chinese medicine combination for treating pain in neck, shoulder, waist and lower extremities
CN104367757A (en) Traditional Chinese medicine composition for treating pains in necks, shoulders, waists and legs
CN102772619B (en) Traditional Chinese medicine for treating bone impediment
CN102342983B (en) Chinese medicinal composition for treating pain in the legs and numbness of the extremities and preparation method of preparation thereof
CN104367921A (en) Traditional Chinese medicine composition for treating pains in necks, shoulders, waists and legs
CN103550380A (en) Traditional Chinese medicine composition for treating hyperostosis
CN104825786A (en) Traditional Chinese medicine composition for treating neck shoulder pain or lumbocrural pain
CN102274293A (en) Muscle and bone relaxing capsules
CN104623476A (en) Traditional Chinese medicine composition for treating osteoproliferation
CN106309992A (en) Traditional Chinese medicine composition for treating osteoproliferation
CN102240351B (en) Traditional Chinese medicine for treating Arthritis, hyperosteogeny, cervical disc herniation and cervical spondylosis
CN105688051A (en) Traditional Chinese medicine composition for treating neck-shoulder pain and lumbocrural pain
CN105535643A (en) Traditional Chinese medicine composition for treating pain in neck, shoulders, waist and legs
CN105395772A (en) Traditional Chinese medicine composition for treating fractures and pains in neck, shoulder, low back and leg
CN105687944A (en) Traditional Chinese medicine composition for treating cervical spondylosis and lumbar spondylosis
CN102552843B (en) Medicament composite for curing osteoarthropathy
CN102743463B (en) Bonesetting decoction promoting bone healing
CN110507796A (en) A kind of Chinese medicine preparation for treating a variety of diseases
CN103784765A (en) Pharmaceutical composition for treating pains
CN105943985A (en) Traditional Chinese medicine composition for treating rheumatic pain
CN105311571A (en) Traditional Chinese medicine composition for treating bone fractures and neck shoulder pain or lumbocrural pain
CN105902918A (en) Chinese medicinal composition for treating neck-shoulder-waist-leg pains

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170111

RJ01 Rejection of invention patent application after publication